跳到正文
openFDA 已分级药品召回执法报告·· 12 天前精选AI 评分66

FDA 执法报告 D-0158-2027:Preferred Pharmaceuticals 人工泪液因无菌保证不足被列为 Class II 召回

FDA drug enforcement D-0158-2027: Preferred Pharmaceuticals, Inc. — Lack of Assurance of Sterility

AI 导读

FDA 执法报告 D-0158-2027 将 Preferred Pharmaceuticals 的人工泪液滴眼液召回列为 Class II,原因为无菌保证不足。该召回由企业自愿发起,涉及批号 C2825L、G1825U、D0826A、D1326B,分销范围为全美,数量 480 瓶。召回启动日期为 2026-10-16,报告日期为 2026-11-11,记录状态为 Ongoing。

推荐理由

记录列出四个批号的人工泪液因无菌保证不足被列为 Class II 自愿召回,可用于核对批号与全美分销范围。

正文 · 原文

FDA drug recall enforcement report — D-0158-2027

Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "1250 N Lakeview Ave Ste O",

"address_2": "",

"center_classification_date": "20261030",

"city": "Anaheim",

"classification": "Class II",

"code_info": "Lot C2825L,Exp 2/28/2027 Lot G1825U,Exp 5/28/2027 Lot D0826A,Exp 11/30/2027 Lot D1326B,Exp 11/30/2027",

"country": "United States",

"distribution_pattern": "U.S. Nationwide",

"event_id": "100159",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"MO18"

],

"brand_name": [

"ARTIFICIAL TEARS"

],

"generic_name": [

"GLYCERIN"

],

"manufacturer_name": [

"Preferred Pharmaceuticals Inc."

],

"nui": [

"N0000185370",

"N0000175629",

"N0000184306",

"N0000185001",

"M0000728",

"M0009417"

],

"original_packager_product_ndc": [

"57896-181"

],

"package_ndc": [

"68788-7266-0",

"68788-7266-1"

],

"pharm_class_cs": [

"Allergens [CS]",

"Glycerol [CS]"

],

"pharm_class_epc": [

"Non-Standardized Chemical Allergen [EPC]"

],

"pharm_class_pe": [

"Increased Histamine Release [PE]",

"Cell-mediated Immunity [PE]",

"Increased IgG Production [PE]"

],

"product_ndc": [

"68788-7266"

],

"product_type": [

"HUMAN OTC DRUG"

],

"route": [

"OPHTHALMIC"

],

"rxcui": [

"259581"

],

"spl_id": [

"13d4f649-b797-4911-b171-e4f5a948b4d3"

],

"spl_set_id": [

"dd646c72-8f47-43c6-a734-db0dcc8cd4d1"

],

"substance_name": [

"GLYCERIN",

"HYPROMELLOSE, UNSPECIFIED",

"POLYETHYLENE GLYCOL 400"

],

"unii": [

"PDC6A3C0OX",

"3NXW29V3WO",

"B697894SGQ"

]

},

"postal_code": "92807-1801",

"product_description": "Artificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0",

"product_quantity": "480 bottles",

"product_type": "Drugs",

"reason_for_recall": "Lack of Assurance of Sterility",

"recall_initiation_date": "20261016",

"recall_number": "D-0158-2027",

"recalling_firm": "Preferred Pharmaceuticals, Inc.",

"report_date": "20261111",

"state": "CA",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov